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1166-213 Computed Tomography Guided Evaluation of 
Pulmonary Vein Anatomy Following Percutaneous 
Cryoablation: 12-Month Results
David Szapiro, Benoit Ghaye, Carl Timmermans, Robert F. Dondelinger, Hung-Fat Tse, 
Christoph Geller, Gregory Ayers, Luz-Maria Rodriguez, Chu Liege, Liege, Belgium, 
Academic Hospital Maastricht, Maastricht, The Netherlands
BACKGROUND: Pulmonary vein isolation (PVI), using radiofrequency energy, for treat-
ment of atrial fibrillation (AF) has been associated with complications including pulmo-
nary vein (PV) stenosis or thrombosis. The purpose of this study was to prospectively
evaluate the PV anatomy following cryoablation.
METHODS: 50 patients underwent percutaneous PVI in 3 academic centres. Contrast-
enhanced, single-slice or multi-slice spiral CT (1-2.5 mm thick slices) was obtained
before, 3 and 12 months following PVI. All examinations were read blinded to the loca-
tion(s) of ablation. PVs were evaluated quantitatively and qualitatively: the diameter at
ostium and at 1 cm from ostium were measured. The presence and location of luminal
irregularity or thrombosis was also assessed.
RESULTS: In ablated veins, the mean diameters at ostium were right inferior PV
1.58±0.34, 1.55±0.29 and 1.66±0.15 cm, right upper PV 1.59 ±0.22, 1.53 ±0.24 and
1.47±0.26 cm, left inferior PV 1.29±0.33, 1.24±0.33 and 1.13±0.25 cm, left upper PV
1.73±0.38, 1.70±0.36 and 1.67±0.35 cm before the procedure and, 3 and 12 months
after the procedure respectively. No significant difference (p > 0.05) was found between
diameter in ablated versus not ablated veins before and after the procedure. Three
patients presented with luminal irregularity before the procedure. No patient showed
luminal irregularity or thrombosis of PV following cryo-ablation.
CONCLUSION: These results suggest that PVI for the treatment of AF is not associated
with stenosis or thrombosis of cryoablated PVs after one year follow-up.
1166-214 Usefulness of a Ventricular Extrastimulus From the 
Summit of the Ventricular Septum in Diagnosis of 
Septal Accessory Pathway
Takehiko Matsushita, Nitish Badhwar, Kathryn K. Collins, George F. Van Hare, Byron K. 
Lee, Randall J. Lee, Melvin M. Scheinman, University of California, San Francisco, San 
Francisco, CA
Background: A ventricular extrastimulus (VES) delivered when the His bundle is refrac-
tory that advances the subsequent atrial deflection proves the existence of an accessory
pathway (AP). Moreover, a VES delivered during His bundle refractoriness which termi-
nates the tachycardia without succeeding atrial activation proves participation of the AP
in the tachycardia circuit. The purpose of the study was to compare delivery of a VES
from the right ventricular (RV) apex versus the summit of the RV septum in patients with
a single septal AP.
Methods: In a retrospective analysis of 16 consecutive patients with a septal AP, a VES
from the RV apex delivered at the time of His deflection during tachycardia resulted in
advancement of the succeeding atrial deflection in 5 and terminated the tachycardia with-
out subsequent atrial depolarization in 2 patients. We prospectively analyzed the data in
a separate group of 12 patients with a septal AP in which a VES was delivered from the
RV apex and then from the RV summit at the time of His deflection during tachycardia.
Results: RV apical VES advanced the succeeding atrial deflection in 3 patients and ter-
minated the tachycardia in another 3 patients. In contrast, RV summit VES advanced the
succeeding atrial deflection in 4 and terminated the tachycardia in 6 patients. RV summit
VES resulted in a significantly higher diagnostic yield for the presence of a septal AP
compared with RV apical VES (83% vs. 46%, P <0.05). RV summit VES also resulted in
a higher diagnostic yield for proof of participation of a septal AP in the tachycardia circuit
compared with RV apical VES (50% vs. 18%, P <0.05). A VES from the RV summit was
diagnostic of presence of an AP in all patients with a right-sided septal AP but in only 1
out of 3 patients with a left posteroseptal AP.
Conclusion: A VES during His bundle refractoriness from the RV summit increases the
diagnostic yield for both presence of an AP and its participation in the tachycardia circuit
with respect to RV apical VES.
1166-215 Atrial Fibrillation Surgery in Patients With Coronary 
Artery Disease
Thomas Deneke, Krishna Khargi, Peter H. Grewe, Thomas Lawo, Frank Kuschkowitz, 
Bernd Calcum, Axel Laczkovics, Andreas Mügge, Bernd Lemke, University of Bochum, 
Bochum, Germany
Atrial fibrillation (AF) is known to be a risk factor for quality of life and increased mortality.
Patients with coronary artery disease undergoing open heart bypass surgery (CABG)
often have associated AF. Is antiarrhythmic surgery in patients undergoing CABG safe
and effective and is there a subgroup of patients who will benefit most?
Methods: 52 consecutive patients (ejection fraction 54±15%, age 69±7years) with
chronic permanent AF (11±10years) underwent CABG (only CABG in 32, CABG plus
mitral valve surgery in 20 due to ischemic mitral valve insufficiency) plus additional intra-
operative cooled-tip radiofrequency ablation to treat AF (aortic clamp 98±22minutes,
bypass time 164±41minutes) treating the left atrium alone in 26 and both atria in 26
patients.
Results: Out of the total of 52 patients 39 converted to stable sinusrhythm (SR) during a
mean follow-up of 23±16months ranking up to a 12-month estimated rhythm-success
percentage of 80% (3 months 31/44 patients: 70%, 6 months 35/44 patients: 80%, 12
months 28/36 patients: 78%). At 6 months follow-up 79% of patients in SR had docu-
mented biatrial contraction. There is no significant difference in rhythm outcome when
one or both atria are treated (86% versus 75%, p=0.24). During follow-up up 9 patients
died (30-day mortality 8%) ranking up to a cumulative 12-months survival rate of 85%.
Patients undergoing CABG procedure alone had a significantly higher survival in short
and long term follow-up compared to patients undergoing additional mitral valve surgery
(30-day mortality 3% versus 15%, p=0.038; 12-month survival 94% versus 70%,
p=0.049). Conversion rates did not differ significantly in between the two groups (74%
versus 94%, p=0.31).
Conclusions: Intraoperative cooled-tip radiofrequency ablation in the atria can safely and
effectively be added to an open heart surgery in patients with coronary artery disease
and the ablation procedure is equally effective independent to the number of atria treated
(left versus biatrial). Patients with additional mitral valve disease have a worse outcome
in regard to survival but not when considering rhythm outcome. In over 60% of these
patients an anticoagulation regimen may be stopped.
1166-216 Efficacy of Cryoablation for Treatment of Paroxysmal 
Atrial Fibrillation
Hugh Calkins, Mark Wood, Emile Daoud, Neil Kay, Greg Feld, Robert Hoyt, Johns 
Hopkins, Baltimore, MD
Background: Electrical isolation of the pulmonary veins (PV) by radiofrequency catheter
ablation (RFCA) has been shown to be an effective treatment for paroxysmal atrial fibril-
lation (PAF). However, RFCA has been associated with a significant incidence of PV
stenosis. Experimental and early clinical studies have shown that catheter cryoablation of
the PVs is also effective in curing PAF, but without causing PV stenosis.
Methods: Therefore, we performed PV cryoablation using a 10Fr cryoablation catheter
system (CryoCor, Inc) in 31 patients (pts), of whom 23 were males, mean age 56±9 yrs
with drug refractory PAF (failure of 2.1±1.1 drugs pre-procedure) Of these pts, 8 also had
a history of atrial flutter (AFL). All pts underwent map-guided, segmental, pulmonary vein
isolation, with success defined as complete elimination of PV potentials. Event recording,
both symptomatic and scheduled, was used to capture arrhythmia episodes prior to and
for 6 months following cryoablation. Patients underwent spiral CT scans to evaluate PV
diameter at baseline, 3 and 6 months after ablation.
Results: There were 29/31 pts (94%) successfully treated in the index procedure with 86
of 90 veins ablated (96%). At 6 months follow-up there were 13/23 pts (57%) without
recurrence of PAF. Of the 10 pts with recurrent AF, 5 pts had a second ablation using RF
at 2.8±0.87 months. During the 6 months following the index procedure the average fre-
quency of AF episode in RF re-treated pts was 0.94±1.0/month, whereas the average
frequency of AF episodes of those not re-treated was 0.9±1.2/month. In the 13 pts in
sinus at 6 months, 8 were on anti-arrhythmic drugs, 2 of whom were on beta-blockers
only. Of the 23 pts who underwent spiral CT scan at 6 months, none had PV stenosis.
Conclusion: The initial results of this pilot study show that cryoablation can be used as a
single treatment for PAF with 6-month efficacy of 57%. Cryoablation appears to be with-
out risk of PV stenosis.
1166-217 Lone Atrial Fibrillation: A Benign Disease? Data of the 
RACE Study
Michiel Rienstra, Vincent E. Hagens, Hans A. Bosker, Otto Kamp, J. Herre Kingma, Harry 
J. Crijns, Isabelle C. Van Gelder, The RACE Investigators, University Hospital Groningen, 
Groningen, The Netherlands
Background - In patients with persistent atrial fibrillation (AF) rate control is not inferior
to rhythm control regarding morbidity and mortality. With lone AF, outcome of a rate and
rhythm control strategy may differ from that in patients with AF in the setting of underlying
heart disease (UHD). The aim of this study was to compare morbidity, mortality and qual-
ity of life (QoL) under rate or rhythm control in patients with lone AF and AF in UHD.
Methods - In the RAte versus Electrical cardioversion (RACE) study, 522 patients were
randomized to rate or rhythm control. A total of 108 patients had lone AF. The occurrence
of cardiovascular endpoints (components see table) and QoL (using SF-36 question-
naire) were compared between patients with and without UHD.
Results - Patients with lone AF were younger (66±10 vs 69±8 years, p=0.001), suffered
for a shorter period from AF (p=0.004) and had less complaints of fatigue (p=0.02) and
dyspnea (p=0.000) compared to those with UHD. With lone AF, QoL at baseline was
higher. Mean follow-up was 2.3±0.6 years. Cardiovascular endpoints occurred in 9% (10)
of the patients with lone AF, 7 under rate and 3 under rhythm control, and in 23% (94) of
the patients with UHD. QoL did not largely change in both groups towards study end.
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Conclusion - In patients with lone AF treated with rate or rhythm control, cardiovascular
event rate was low, compared to patients with UHD. QoL is higher in patients with lone
AF. Event rate with lone AF was too small to assess whether to prefer rate or rhythm con-
trol.
1166-218 Modification of Electrophysiologic Properties of 
Pulmonary Veins and Adjacent Left Atrial Tissue by 
Radiofrequency Circumferential Ablation of the 
Pulmonary Vein Ostia: Correlation With Nonrecurrence 
of Atrial Fibrillation
Hiroshi Sohara, Shyutaro Satake, Kazushi Tanaka, Sugako Ishigaki, Yoshio Yamaguchi, 
Shigeru Saito, Yoshio Watanabe, Shonan Kamakura General Hospital, kamakura, Japan
Background: Electrical disconnection between pulmonary veins (PVs) and left atrium
(LA) is now frequently used in the treatment paroxysmal atrial fibrillation (AF). Ablation of
PVs per se is, however, time consuming and is often complicated with PV stenosis. Fur-
thermore, the rate of recurrence is rather high perhaps due to anatomical variations of
PV-LA junctional area. Hence, we tested the efficacy of PV ostial ablation with a novel
radio-frequency balloon catheter (RBC) and elucidated the electrophysiologic changes
required for the maintenace of sinus rhythm.
Methods and Results: Forty-nine patients with drug-resistant AF underwent circumferen-
tial ablation of PV-LA junction by RBC. Post ablation changes in electrophysiologic prop-
erties around the PV ostia were studied with a basket catheter and were correlated with
AF recurrence in 34 early cases (ablating 68 superior PVs) and 15 later cases (53 supe-
rior and inferior PVs). Total elimination of PV potentials or PV-LA dissociation was
achieved in 92.7% (63/68 PVs) and 92.5% (49/53 PVs), respectively. During mean follow-
up periods of 15.1+/-4.8 and 6.2+/-2.2 months, AF recurred in 38.2%(13/34cases) and
13.3%(2/15) in early and later groups, but no case developed PV stenosis. Although the
amplitude of PV and periostial LA potentials were decreased (p<0.0001) in all patients,
the remaining PV potentials in 34 nonrecurrence cases were definitely smaller than those
in 15 recurrence cases (p<0.0001). When a cut-off level of less than 0.4 mV in receiver
operating characteristic curves was used, its negative predictive value for non-recurrence
of AF was 93% and specificity was 95.2%.
Conclusions: Circumferential PV ostial ablation with an RBC is highly effective in termi-
nating AF without the risk of PV stenosis. Maintenance of sinus rhythm can be predicted
when both supeior and inferior PVs are ablated and amplitudes of all the remaining PV-
LA potentials are decreased to less than 0.4mV.
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1167-207 Improved Response Rate and Left Ventricular Epicardial 
Lead Stability Following Robotically-Assisted 
Ventricular Resynchronization
Sandhya K. Balaram, Robert C. Ashton, Jr., Jonathan S. Steinberg, Daniel G. Swistel, 
Frederick Ehlert, Margot E. Vloka, Joseph J. DeRose, Jr., St. Luke's-Roosevelt Hospital 
Center, Columbia University College of Physicians and Surgeons, New York, NY
Background: Robotically-assisted left ventricular (LV) epicardial lead implantation is a
safe and effective technique for biventricular pacing. We hypothesized that such a strat-
egy for ventricular resynchronization therapy might produce improved clinical response
rates over the medium term.
Methods: Twenty patients with congestive heart failure (NYHA Class 3.5 ± 0.5) and a
widened QRS (184 ± 30 msec) underwent robotic LV lead placement for biventricular
pacing. Mean patient age was 69.4 ± 11.6 years, LV ejection fraction (EF) was 12.3 ± 6%
and left ventricular end diastolic volume was 6.8 ± 1.2 cm. The etiology of heart failure
was ischemic in 55% and idiopathic in 45%. Ten patients (50%) had prior coronary artery
bypass surgery. Indications for robotic LV lead implant included failure of coronary sinus
cannulation (10), atretic venous tributaries (4), poor LV lead capture (3), primary implant
(2) and coronary sinus dissection (1).
Results: Two epicardial leads were placed on the posterolateral surface of the LV in all
patients as directed by intra-operative electrophysiologic mapping. Implant success rate
was 100%. Intraoperative lead threshold was 1.2 ± 0.6 v at 0.5 ms, R-wave was 14.4 ±
8.7 mv, and impedance was 1098 ± 220 ohms at 0.5 v. Complications included one post-
operative pneumonia, one intraoperative LV injury and one episode of post-operative
renal insufficiency. At an average follow-up of 8.5 ± 4.4 months, 19 of 20 patients are
alive and well. Improvements in exercise tolerance have been demonstrated in 85% of
patients and there have been no lead failures over the follow-up period. Statistically sig-
nificant improvements in ejection fraction (19.9 ± 13%, p=0.03) and QRS duration (149 ±
21 msec, p=0.007) have also been measured. Over the medium-term lead thresholds
have remained unchanged (1.8 ± 1.1V at 0.5 ms, p=ns), and a significant drop in imped-
ance (310 ± 54 ohms, p=0.005) has been detected.
Conclusions: Robotic LV epicardial leads remain stable and reliable over the medium
term. Improved clinical response rates may be achieved with the site directed implanta-
tion strategy that this technique affords.
1167-208 Relationship Between QRS Duration and Left 
Ventricular Dyssynchrony in Patients With End Stage 
Heart Failure
G. B. Bleeker, M. J. Schalij, S. G. Molhoek, H. F. Verwey, E. E. van der Wall, J. J. Bax, 
Leiden University Medical Center, Leiden, The Netherlands
Background: Patients with end-stage heart failure and wide QRS complex are consid-
ered candidates for cardiac resynchronization therapy (CRT). A wide QRS complex is
considered to represent left ventricular (LV) dyssynchrony. However, 20-30% of these
patients do not respond to CRT. Tissue Doppler Imaging (TDI) may provide more accu-
rate information on intra-LV dyssynchrony. Accordingly we evaluated a large cohort of
patients with different QRS durations with TDI to assess LV dyssynchrony.
Methods: 90 consecutive patients with severe heart failure (LVEF<35%, NYHA class III-
IV) were divided into 3 groups of 30 patients based on QRS duration. (<120ms, 120-150
ms and > 150ms). All patients underwent TDI to assess LV dyssynchrony and QRS dura-
tion was compared to the septal-to-lateral delay (S-L delay), a direct marker of LV dys-
synchrony. Based on previous work, an S-L delay >60 ms was considered indicative of
severe LV dyssynchrony.
Results: Severe dyssynchrony was observed in 8 patients (27%) with narrow QRS com-
plex (<120 ms), in 18 patients (60%) with a QRS duration of 120-150 ms, and in 21
patients (70%) with QRS > 150 ms (see figure). No relation existed between QRS dura-
tion and S-L delay.
Conclusions: QRS duration does not adequately reflect intra LV dyssynchrony and TDI
should be used alternatively. In addition, 27% of patients with heart failure and narrow
QRS complex have dyssynchrony and may be candidates for CRT.
1167-219 Long-Term Reliability of Epicardial and Transvenous 
Leads Used for Cardiac Resynchronization Therapy
John D. Hummel, Leslie A. Saxon, Jerry Luck, David Meyer, Patrick Yong, The VIGOR 
CHF/VENTAK CHF CONTAK CD Study Investigators, Riverside Methodist Hospital, 
Columbus, OH, Guidant Corporation, St. Paul, MN
Background: Left ventricular pacing leads used in cardiac resynchronization therapy are
either placed in the coronary venous vasculature transvenously (TRANS) or surgically
implanted transthoracically on the epicardium (EPI) via limited thoracotomy. A long-term
comparison of the reliability of these leads in heart failure patients (pts) has not been pre-
viously discussed.
Methods: Pts participating in the VIGOR CHF and VENTAK CHF/CONTAK CD studies
had either TRANS (443 pts) or EPI (109 pts) leads implanted. EPI leads were either ste-
roid eluting sutureable (SUT, 81 pts) or non-steroid eluting screw-in myocardial (MYO, 28
pts). A Kaplan-Meier estimate of the time to lead failure or replacement was calculated
for TRANS vs. EPI as well as for SUT vs. MYO leads. Pt deaths and explants due to heart
transplant or infection were censored at the time of the event.
Results: Revision was required in 44 TRANS (10%) and 26 EPI (24%) leads [9 MYO
(32%) and 17 SUT (21%)]. Failure in TRANS leads was typically due to dislodgment
while that of EPI leads was usually due to exit block or lead fracture. TRANS leads were
significantly more reliable than EPI (hazard ratio=2.5, p=0.0003). SUT trended to greater
reliability than MYO (hazard ratio=2.1, p=0.08).
Incidence of the primary endpoint and its components
Lone AF AF with UHD
Rate control 
(n=53)
Rhythm 
control (n=55)
Rate control 
(n=203)
Rhythm control 
(n=211)
Endpoint - no.(%) 7 (13) 3 (5) 37 (18) 57 (27)
Cardiovascular 
mortality
2 (4) 1 (2) 16 (8) 17 (8)
Heart failure 0 0 9 (4) 12 (6)
Thromboembolic 
complications
2 (4) 1 (2) 12 (6) 20 (9)
Bleeding 4 (8) 1 (2) 8 (4) 8 (4)
Side effects of 
antiarrhythmic drugs
0 0 2 (1) 12 (6)
Pacemaker implants 1 (2) 1 (2) 2 (1) 7 (3)
